2026-10-25
Friedman Industries clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,944 +1.18%
S&P 7,385 +0.42%
GOLD $4,067 −1.12%
BTC $75,586 −0.47%
VIX 25.28 −10.29%
latest tape · as of 18:01 UTC
The Screen · Basic Materials · Steel
Friedman Industries Inc
FRD · NASDAQ · USD · Market cap $302M · 381 employees
Friedman Industries, Incorporated engages in the manufacture and processing of steel products in the United States.
Not yet scored35.50 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 18:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price35.50 USD at the 5 Nov 2026 close
- Our regime readMarkdown, as of 5 Nov 2026
- Ethical screenNot yet scored
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: range not available (screen dated 2026-11-05).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price35.50 USD
Ethical score70.0/100
Our investment reviews on this name
2026-11-05Read Markdown38.79-8.5% to today ✓Accumulation gives way to Markdown after an 8% slide in 3 weeks
2026-10-14Read Accumulation41.98-15.4% to today Markdown gives way to Accumulation after a 5% rise in 12 days
2026-10-02Read Markdown39.96-11.2% to today ✓Markup gives way to Markdown after a 15% rise in 13 weeks
2026-07-02Read Markup34.72+2.2% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Friedman Industries Inc holds its Markdown at $35.50. The statistical read favours the sellers, held for 32 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 32 days |
| Price at the screen | $35.50 |
| Valuation | 10.89 trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.65 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 29.73% | Below 33% | Interest-bearing debt is just 29.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 24.53% | Below 49% | Money owed to the company is 24.5% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Friedman Industries clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Friedman Industries clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
The Business, in Plain Words| Trailing P/E | 10.9xreasonably valued |
| EPS, trailing | 3.84 |
| Revenue growth | +78.1%growing very fast |
| Profit margin | 3.6%barely profitable |
| Return on equity | 18.1%a solid return on shareholder capital |
| FCF yield | -17.04% |
| Dividend yield | 46.00% |
| Debt to equity | 0.62moderate, manageable leverage |
| Current ratio | 2.90comfortably covers its short-term bills |
| Beta | 1.65much more volatile than the market |
| Short interest, float | 0.02% |
| 52-week range | 16.55 - 48.77 |
| Moat | NONE |
| Market cap | $302M |
| Employees | 381 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFRD trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-05
Markdown · changed $38.79
-7.3% Entry 9
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-10-28
Accumulation $41.83
-0.4% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.4% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%. Since the last review it dropped out of the Titan Ethical 500.
2026-10-14
Accumulation · changed $41.98
+5.1% Entry 7
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-10-02
Markdown · changed $39.96
-9.6% Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-08-29
Markup $44.21
+29.7% Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 29.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-07-30
Markup $34.09
-1.8% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-07-18
Markup $34.72
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 55%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-07-03
Markup $34.72
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02
Markup $34.72
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Friedman Surges More Than 127% in 6 Months: What's Driving the Stock? Yahoo Finance · 24d ago
- Friedman Industries Announces Rebrand of Texas Tubular Products to Friedman Tubular Yahoo Finance · 29d ago
- Revisiting 2 Outperform Microcaps Yahoo Finance · 5 Oct 2026
- Top Stock Reports for Visa, Intuitive Surgical & Williams Companies Yahoo Finance · 29 Sep 2026
- Friedman Industries, Incorporated Announces Cash Dividend Yahoo Finance · 22 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
MSBMesabi Trust
ASTLAlgoma Steel Group Inc
HLPHongli Group Inc
INHDInno Holdings Inc
MTUSMetallus Inc.
NWPXNWPX Infrastructure, Inc.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $21.43 | +19.4% | · | $1,194 | +19.4% |
| 2 months | $18.26 | +40.2% | $0.04 | $1,404 | +40.4% |
| 3 months | $16.99 | +50.7% | $0.04 | $1,509 | +50.9% |
| 6 months | $20.15 | +27.0% | $0.08 | $1,274 | +27.4% |
| 1 year | $16.50 | +55.1% | $0.16 | $1,561 | +56.1% |
| 2 years | $15.65 | +63.5% | $0.32 | $1,656 | +65.6% |
| 3 years | $9.60 | +166.5% | $0.42 | $2,709 | +170.9% |
| 5 years | $12.90 | +98.4% | $0.58 | $2,028 | +102.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FRD does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.